Aandeel 8432 TSH BIOPHARM CORPORATION LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen TSH Biopharm Corporation Limited

Aandelen

8432

TW0008432006

slotkoers Taipei Exchange
Andere beurzen
 00:00:00 07-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
62,3 TWD +3,15% Intraday-grafiek van TSH Biopharm Corporation Limited +3,32% +23,86%
11/03 TSH Biopharm Corporation Limited kondigt directiewisselingen aan op 1 april 2024 CI
28/02 TSH Biopharm Corporation Limited rapporteert resultaten voor het gehele jaar dat eindigde op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024
TSH Biopharm Corporation Limited Appoints Jung-Liang Kao as CFO on April 1, 2024
TSH Biopharm Corporation Limited agreed to acquire an unknown stake in TOP Pharm. Medicalware Company Limited from Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd., ANIMATO INTERNATIONAL COMPANY, Shen Feng Co., Ltd. and others for TWD 257.1 million.
TSH Biopharm Corporation Limited agreed to acquire 51% stake in TOP Biological Technology Company Limited from Shen Feng Co., Ltd., Gu An Engineering Consultants Co., Ltd., Kao Tuan International Consulting Co., Ltd. ANIMATO INTERNATIONAL COMPANY and others for TWD 44.3 million.
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023
TSH Biopharm Corporation Limited Announces the Change of Financial Officer, Effective on January 1, 2024
TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Tsh Biopharm Corporation Limited Announces the Change of Audit Committee Members
Tsh Biopharm Corporation Limited Announces Dividend for the Year 2022, Payable on July 14, 2023
TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022
TSH Biopharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2022
TSH Biopharm Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
TSH Biopharm : is invited to attend the online institutional investor conference hosted by IBF Securities
TSH Biopharm : Board of Directors Approved Financial Statements For the Six Months Ended June 30, 2022
TSH Biopharm : Announcement of setting up the Sustainable Development Committee and members of TSH's first Sustainable Development Committee
TSH Biopharm Corporation Limited Announces Board Appointments
TSH Biopharm Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
TSH Biopharm : was invited to attend the online institutional investor conference hosted by Concord Securities
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 8432
  4. Nieuws TSH Biopharm Corporation Limited
  5. Andere talen